You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美瑞健康國際(02327.HK):雲南漢素作為第一大股東的雲南漢盟製藥股權轉讓及增資事項取得進展
格隆匯 10-09 21:01

格隆匯10月9日丨美瑞健康國際(02327.HK)公佈,於2019年10月8日,本公司接獲了雲南漢素通知,雲南漢素作為第一大股東的雲南漢盟製藥有限公司股權轉讓及增資事項取得進展;此交易事項的評估結果已獲得股權受讓及增資方(一家A股上市公司)的實際控制人備案,經備案的評估結果與前期相關第三方的評估報告一致。

在此之前,於2019年4月8日,該股權受讓方公告擬通過其下屬全資子公司以人民幣2億元為對價受讓雲南漢素持有的漢盟37.14%股權,並擬同時對漢盟增資不超過人民幣1.38億元。雲南漢素對漢盟的出資額為人民幣1600萬元,故是次交易將為雲南漢素帶來可觀的收益。截止至本公告日,雲南漢素已經從該股權受讓方收到人民幣7000萬元的定金,並將收到剩餘的轉讓對價人民幣1.3億元。

交易完成後,雲南漢素將不再持有漢盟的任何股權。本集團持有云南漢素的25.55%股權,是雲南漢素的第二大股東,並且在雲南漢素擁有一個董事席位。

據本公司董事所深知,雲南漢素作為全球一流、中國領先的大麻素萃取及下游應用廠商之一,不斷致力於推動先進萃取方案的應用及輸出,並於2019年7月22日變更其企業經營範圍,增加生物技術轉讓一項。此次漢盟的股權轉讓及增資的順利推進證明雲南漢素的萃取方案已獲得市場認可,公司相信新的經營範圍將進一步推動雲南漢素豐富自身的商業模式、增加其收入範圍及提升其經營盈利狀況。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account